Skip to main content

8-K

Pulmatrix, Inc. (PULM)

8-K 2022-06-15 For: 2022-06-15
View Original
Added on April 08, 2026
View as plain text


UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

WASHINGTON,

D.C. 20549

FORM

8-K



CURRENT

REPORT

Pursuant

to Section 13 or 15(d) of the

Securities

Exchange Act of 1934

Dateof Report (Date of earliest event reported): June 15, 2022

PULMATRIX,

INC.

(Exactname of registrant as specified in its charter)

Delaware 001-36199 46-1821392
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

99Hayden Avenue, Suite 390

Lexington,MA 02421

(Addressof principal executive offices) (Zip Code)

(781)357-2333

(Registrant’stelephone number, including area code)

N/A

(Formername or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of exchange on which registered
Common Stock, par value $0.0001 per share PULM The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 15, 2022, Pulmatrix, Inc. (the “Company”) held its 2022 annual meeting of stockholders (the “Annual Meeting”). A total of 1,490,945 shares of the Company’s common stock were present in person or represented by proxy at the Annual Meeting, which represented 44.02% of the outstanding shares of common stock entitled to vote at the Annual Meeting and constituted a quorum for the transaction of business. Holders of the Company’s common stock were entitled to one vote per share of common stock held as of the close of business on April 18, 2022, the record date for the Annual Meeting. The matters submitted for a vote and the related results are set forth below.

(1) Election<br> of two directors to serve as Class II directors on the Company’s Board of Directors to serve until the Company’s 2025<br> annual meeting of stockholders or until successors have been duly elected and qualified:
Director For Against Withheld /Abstained Broker Non-Votes
--- --- --- --- --- --- --- --- ---
Teofilo Raad 422,137 - 178,197 890,611
Richard Batycky, Ph.D. 448,559 - 151,775 890,611
(2) Ratification<br> of the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the 2022 fiscal year:
--- ---
For Against Withheld /Abstained Broker Non-Votes
--- --- --- --- --- --- --- ---
1,378,659 97,469 14,817 0

For more information about the foregoing proposals, see the Company’s definitive proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission on April 29, 2022, the relevant portions of which are incorporated herein by reference.

The results reported above are final voting results. No other matters were considered or voted upon at the meeting.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PULMATRIX, INC.
Date:<br> June 15, 2022 By: /s/ Teofilo Raad
Teofilo<br> Raad
Chief<br> Executive Officer